A crucial factor of regenerative treatment and drug research lies in the ability to multiply human stem cell groups to sufficient numbers for therapeutic applications. Traditionally, restricted cell supply posed a significant barrier to progress in these fields. Consequently, considerable work has been directed towards optimizing methods for stem c